Angiotensinogen T174M and M235T gene polymorphisms are associated with the extent of coronary atherosclerosis

Atherosclerosis

Volumn 145, Issue 2, 1999, Pages 309-314

  Gardemann, Andreas ^a   Stricker, Jürgen ^a   Humme, Jörg ^a   Nguyen, Quoc D ^a   Katz, Norbert ^a   Philipp, Monika ^a   Tillmanns, Harald ^a   Hehrlein, Friedrich Wilhelm ^b   Haberbosch, Werner ^c  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c KERCKHOFF HEART CENTER   (Germany)

Author keywords

Angiotensinogen gene; Cardiovascular disease; Gensini score; Myocardial infarction; Renin angiotensin aldosteron system; Risk factors

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CAUCASIAN; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY RISK; DNA POLYMORPHISM; GENE FREQUENCY; GENOTYPE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0032794997     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00082-9     Document Type: Article

References (27)

1. Powell JS, Clozel JP, Muller RKM, Kuhn H, Hefti F, Hosang M, et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989;245:186-8.
2. Chobanian AV, Haudenschild CC, Nickerson C, Drago R. Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension 1990;15:327-31.
3. Aberg G, Ferrer P. Effects of captopril on atherosclerosis in cyomolgus monkeys. Cardiovasc Pharmacol 1990;15(Suppl 15):S65-S72.
4. Wang DH, Prewitt RL. Captopril reduces aortic and microvascular growth in hypertensive and normotensive rats. Hypertension 1990;15:68-77.
5. The SOLVD investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. New Engl J Med 1991;325:293-302.
6. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ, Cuddy TE, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. New Engl J Med 1992;327:669-77.
7. Ambrosioni E, Bacchelli S, Degli Esposti D, Borghi C. ACE-inhibitors and atherosclerosis. Eur J Epidemiol 1992;8(Suppl 2):129-33.
8. Dzau VJ, Sasamura H, Hein L. Heterogeneity of angiotensin synthetic pathways and receptor subtypes: physiological and pharmacological implications. J Hypertens 1993;11:S13-8.
9. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-4.
10. Singer DRJ, Missouris CG, Jeffery S. Angiotensin-converting enzyme gene polymorphism. What to do about all the confusion? Circulation 1996;94:236-9.
11. Samani NJ, Thompson JR, O'Toole L, Channer K, Woods KL. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme with myocardial infarction. Circulation 1996;94:708-12.
12. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer M, Grodstein F, La Motte F, et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995;332:706-11.
13. Agerholm-Larsen B, Nordestgaard BG, Steffensen R, Sorensen TIA, Jensen G, Tybjaerg-Hansen A. ACE gene polymorphism: ischemic heart disease and longevity in 10150 individuals. A case-referent and retrospective cohort study based on the Copenhagen City Heart Study. Circulation 1997;95:2358-67.
14. Gardemann A, Fink M, Stricker J, Nguyen QD, Humme J, Katz N, Tillmanns H, Hehrlein FW, Rau M, Haberbosch W. ACE I/D gene polymorphism: presence of the ACE D allele increases the risk of coronary artery disease in younger individuals. Atherosclerosis 1998;139:153-9.
15. Tiret L, Bonnardeaux A, Poirier O, et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 1994;344:910-3.
16. Russ AP, Maerz W, Ruzicka V, Stein U, Gross W. Rapid detection of the hypertension-associated Met235→Thr allele of the human angiotensinogen gene. Hum Mol Genet 1993;2:609-10.
17. Katsuuya T, Koike G, Yee TW, Sharpe N, Jackson R, Norton R. Association of angiotensinogen gene T235 variant with increased risk of coronary artery disease. Lancet 1995;345:1600-3.
18. Ludwig EH, Borecki EB, Ellison RC, Folsom AR, Heiss G, Hiffins M, et al. Associations between candidate loci angiotensin-converting enzyme and angiotensinogen with coronary heart disease and myocardial infarction: the NHLBI family heart study. Ann Epidemiol 1997;7:3-12.
19. Ko YL, Ko YS, Wang SM, Chu PH, Teng MS, Cheng NJ, et al. Angiotensinogen and angiotensin I converting enzyme gene polymorphisms and the risk of coronary artery disease in Chinese. Hum Genet 1997;100:210-4.
20. Yamakawa-Kobayashi K, Arinami T, Hamaguchi H. Absence of association of angiotensinogen gene T235 allele with increased risk of coronary heart disease in Japanese. Lancet 1995;346:515.
21. Tiret L, Ricard S, Poirier O, Arveiler D, Cambou JP, Luc G, et al. Genetic variation at the angiotensinogen locus in relation to high blood pressure and myocardial infarction. J Hypertens 1995;13:311-7.
22. Gensini GG. Coronary arteriography. In: Braunwald E, editor. Heart disease. Philadelphia: Saunders, 1980:352-3.
23. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983;51:606.
24. Hegele RA, Brunt H, Connelly PW. A polymorphism of the angiotensinogen gene associated with variation in blood pressure in a genetic isolate. Circulation 1994;90:2207-12.
25. Schmidt S, Giessel R, Bergis KH, Strojek K, Grzeszczak W, Ganten D, et al. Angiotensinogen gene M235T polymorphism is not associated with diabetic nephropathy. Nephrol Dial Transplant 1996;11:1755-61.
26. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Ricard S, et al. Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy. Diabetes 1996;45:367-9.
27. Jeunmaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992;71:169-80.